<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01326520</url>
  </required_header>
  <id_info>
    <org_study_id>LSEP H49-11</org_study_id>
    <nct_id>NCT01326520</nct_id>
  </id_info>
  <brief_title>Effect of Dietary Phospholipids on Atopic Dermatitis</brief_title>
  <official_title>Effect of Dietary Milk Phospholipids on Subjects With Atopic Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jena</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the influence of a milk phospholipid enriched dairy
      product on subjects with atopic dermatitis determining parameters of the immune status, the
      plasma lipid profile and the skin texture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Based on the facts, that on the one hand milk phospholipids are characterized by a high
      sphingolipid content and on the other hand a disturbed sphingolipid metabolism in the
      epidermis of patients with atopic dermatitis was verified, a double blinded, controlled,
      randomized, cross-over study with a daily supplementation of 3 g milk phospholipids to
      subjects with a mild to moderate atopic dermatitis will be conducted.

      Forty patients will be randomized between two groups of each 20 patients. After an individual
      checkup and a run-in period of 2 weeks, the one group will receive the phospholipid enriched
      dairy product and the second group will be given a placebo dairy product over two month. A
      wash out-period of 4 weeks will follow, and the patients will consume the contrary dairy
      products over two month after a 2-week run-in period again.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in skin texture from baseline and in comparison with placebo</measure>
    <time_frame>after 0,2,10,16, and 24 weeks</time_frame>
    <description>SCORAD Index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immune status</measure>
    <time_frame>after 0,2,10,16, and 24 weeks</time_frame>
    <description>total IgE, specific IgE, sE selectin, Interferon-gamma, Tumor necrosis factor-alpha, Interleukin 4, 12, 16, 31</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid status</measure>
    <time_frame>after 0,2,10,16, and 24 weeks</time_frame>
    <description>Blood lipids (Total cholesterol, LDL cholesterol, HDL cholesterol, triacyl glycerdies, fatty acids, phospholipids)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Dermatitis, Atopic</condition>
  <arm_group>
    <arm_group_label>Phospholipid enriched dairy product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>dairy product</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>milk phospholipid</intervention_name>
    <description>The patients will consume daily 250 mL of a dairy product, which is enriched with 3 g of milk phospholipids.</description>
    <arm_group_label>Phospholipid enriched dairy product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>diary product</intervention_name>
    <description>The patients will consume daily 250 mL of a common dairy product.</description>
    <arm_group_label>dairy product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mild to moderate atopic dermatitis (SCORAD &lt; 30)

          -  age: 18 - 60 years

        Exclusion Criteria:

          -  intolerance against milk proteins

          -  systemic medication with corticosteroids or antihistamines

          -  immune mediated disease

          -  atherosclerosis

          -  hyperlipidaemia

          -  diabetes mellitus

          -  angina pectoris

          -  adipositas

          -  pregnancy and breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Jahreis, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Friedrich Schiller Univesity of Jena, Department of Nutritional Physiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Friedrich Schiller University Jena, Department of Nutritonional Physiology</name>
      <address>
        <city>Jena</city>
        <state>Thuringia</state>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2011</study_first_submitted>
  <study_first_submitted_qc>March 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2011</study_first_posted>
  <last_update_submitted>June 19, 2012</last_update_submitted>
  <last_update_submitted_qc>June 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jena</investigator_affiliation>
    <investigator_full_name>Gerhard Jahreis</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

